Boostrix tdap vaccine syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1U45
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,009
Award facts
- Contract value 100% obligated
- $34,008.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34,008.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringe format, with an ultimate completion date of January 14, 2026. This non-set-aside contract was competitively awarded and reflects the company's ongoing role as a critical pharmaceutical vendor supporting federal healthcare procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc. and serves as a major distributor of pharmaceutical products and medical supplies to military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 and extending through December 2026. The parent IDC enables the company to supply an extensive range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The vaccine delivery represents the type of essential medical commodity routinely procured through this flexible contract vehicle to maintain pharmaceutical readiness across the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F1U45?
SPE2DR26F1U45 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F1U45 worth?
The government has obligated $34,009 on SPE2DR26F1U45.
Is contract SPE2DR26F1U45 an order under another contract?
Yes. SPE2DR26F1U45 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1U45 competed?
The extent of competition for SPE2DR26F1U45 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award